EUVIMEDEUVIMED entdecken
Crossref

Lingguizhugan decoction alleviates gestational diabetes mellitus by modulating the PI3K–AKT pathway and oxidative stress: Network pharmacology and experimental evidence

Chenyue Cao, Weiqin Chen, Bin Chen, Xiaoyu Wang, Yiling Lu, Xueqin Zou, Xinyi Kang, Liping Chen iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.6042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Chenyue Cao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obstetrics and Gynecology Department, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Diabetes, Gestational, Drugs, Chinese Herbal, Proto-Oncogene Proteins c-akt, Oxidative Stress. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: Scientific research project of Nantong Health Commission, Open Project of Jiangsu Province Science and Technology Resources (Major Disease Biological Samples) Integrated Service Platform, Jiangsu Provincial Maternal and Child Health Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Lingguizhugan decoction (LGZGD) is a promising traditional Chinese medicine for the treatment of gestational diabetes mellitus (GDM). However, its bioactive compounds and therapeutic mechanisms remain unknown. The main chemical composition of LGZGD was analyzed by high‐performance liquid chromatography–mass spectrometry (HPLC–MS). Furthermore, the underlying mechanisms of LGZGD against GDM were elucidated through network pharmacology and molecular docking. The therapeutic efficacy and targets of LGZGD were further confirmed via an in vitro GDM model (high glucose [HG]‐treated HTR‐8/SVneo cells). Four compounds of LGZGD, namely, cinnamaldehyde, glycyrrhizic acid, 2‐atractylenolide, and pachymic acid, were detected. A total of 26 targets for LGZGD treating GDM were obtained, which were mainly involved in oxidative stress and the PI3K–AKT signaling pathway. The protein–protein interaction (PPI) network unveiled that AKT1, TLR4, TP53, and NOS3 were hub therapeutic targets. Molecular docking showed that these targets had strong affinity with key compounds. In vitro experiments confirmed that LGZGD treatment promoted HG‐induced cell viability, migration, and invasion ability while inhibited the apoptosis rate and oxidative stress. Mechanically, western blot revealed that LGZGD may protect HG‐treated cells by activating the PI3K–AKT pathway and suppressing TLR4 expression. Our study preliminarily explored the mechanism of LGZGD in GDM treatment, providing a scientific basis for the clinical application of LGZGD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalDrugs, Chinese HerbalProto-Oncogene Proteins c-aktOxidative StressPhosphatidylinositol 3-KinasesMolecular Docking SimulationSignal TransductionNetwork PharmacologyPregnancyHumansFemaleCell LineProtein Interaction MapsChromatography, High Pressure Liquid

Stichwörter der Autor:innen

Lingguizhugan decoctionPI3K–AKT pathwaygestational diabetes mellitusmolecular dockingnetwork pharmacology

Substanzen

Drugs, Chinese HerbalProto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinases

Autor:innen und Institutionen

  • Obstetrics and Gynecology Department, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.
  • Traditional Chinese Medicine Department, The Second Affiliated Hospital of Nantong University, Nantong, Jiangsu, China.

ORCID-Profile: Liping Chen

Förderung

  • Scientific research project of Nantong Health Commission
  • Open Project of Jiangsu Province Science and Technology Resources (Major Disease Biological Samples) Integrated Service Platform
  • Jiangsu Provincial Maternal and Child Health Research Project
  • The Special Project of Nantong University Clinical Medicine
  • Nantong Municipal Commission of Health and Family Planning

Zitieren

APA

Cao, C., Chen, W., Chen, B., Wang, X., Lu, Y., Zou, X., Kang, X., & Chen, L. (2025). Lingguizhugan decoction alleviates gestational diabetes mellitus by modulating the PI3K–AKT pathway and oxidative stress: Network pharmacology and experimental evidence. Biomedical Chromatography. https://doi.org/10.1002/bmc.6042

Vancouver

Cao C, Chen W, Chen B, Wang X, Lu Y, Zou X, et al. Lingguizhugan decoction alleviates gestational diabetes mellitus by modulating the PI3K–AKT pathway and oxidative stress: Network pharmacology and experimental evidence. Biomedical Chromatography. 2025. doi:10.1002/bmc.6042

BibTeX
@article{Cao2025,
  author = {Cao, Chenyue and Chen, Weiqin and Chen, Bin and Wang, Xiaoyu and Lu, Yiling and Zou, Xueqin and Kang, Xinyi and Chen, Liping},
  title = {Lingguizhugan decoction alleviates gestational diabetes mellitus by modulating the PI3K–AKT pathway and oxidative stress: Network pharmacology and experimental evidence},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.6042}
}
Kostenlos starten →